ROCK-isoform-specific polarization of macrophages associated with age-related macular degeneration

ROCK亚型特异性巨噬细胞极化与年龄相关性黄斑变性相关

阅读:1
作者:Souska Zandi ,Shintaro Nakao ,Kwang-Hoon Chun ,Paolo Fiorina ,Dawei Sun ,Ryoichi Arita ,Ming Zhao ,Enoch Kim ,Olivier Schueller ,Stewart Campbell ,Mahdi Taher ,Mark Ivan Melhorn ,Alexander Schering ,Francesca Gatti ,Sara Tezza ,Fang Xie ,Andrea Vergani ,Shigeo Yoshida ,Keijiro Ishikawa ,Muneo Yamaguchi ,Fumiyuki Sasaki ,Ruth Schmidt-Ullrich ,Yasuaki Hata ,Hiroshi Enaida ,Mitsuko Yuzawa ,Takehiko Yokomizo ,Young-Bum Kim ,Paul Sweetnam ,Tatsuro Ishibashi ,Ali Hafezi-Moghadam

Abstract

Age is a major risk factor in age-related macular degeneration (AMD), but the underlying cause is unknown. We find increased Rho-associated kinase (ROCK) signaling and M2 characteristics in eyes of aged mice, revealing immune changes in aging. ROCK isoforms determine macrophage polarization into M1 and M2 subtypes. M2-like macrophages accumulated in AMD, but not in normal eyes, suggesting that these macrophages may be linked to macular degeneration. M2 macrophages injected into the mouse eye exacerbated choroidal neovascular lesions, while M1 macrophages ameliorated them, supporting a causal role for macrophage subtypes in AMD. Selective ROCK2 inhibition with a small molecule decreased M2-like macrophages and choroidal neovascularization. ROCK2 inhibition upregulated M1 markers without affecting macrophage recruitment, underlining the plasticity of these macrophages. These results reveal age-induced innate immune imbalance as underlying AMD pathogenesis. Targeting macrophage plasticity opens up new possibilities for more effective AMD treatment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。